Drug therapy reviews: pathogenesis and clinical management of hyperuricemia and gout
Mangini, R.J.
American Journal of Hospital Pharmacy 36(4): 497-504
1979
ISSN/ISBN: 0002-9289 PMID: 433935 Document Number: 149384
Document emailed within 1 workday
Related Documents
Matzkies, F. 1983: Therapy of hyperuricemia and gout. Effect of a combination therapy of allopurinol with benzbromarone Fortschritte der Medizin 101(20): 953-959Elenbaas, R.M. 1977: Drug therapy reviews: management of the disulfiram-alcohol reaction American Journal of Hospital Pharmacy 34(8): 827-831
Imanishi, M.; Ikegami, M.; Ishii, T.; Nishioka, T.; Uemura, T.; Kunikata, S.; Kanda, H.; Matsuura, T.; Akiyama, T.; Kurita, T. 1990: Clinical studies on hyperuricemia and gout after transplantation Hinyokika Kiyo. Acta Urologica Japonica 36(8): 893-896
Gutman, A.B. 1972: Views on the pathogenesis and management of primary gout--1971 Journal of Bone and Joint Surgery. American Volume 54(2): 357-372
Nakata, T.; Iimura, O. 1992: The management of hyperuricemia associated with drug treatment of hypertension Nihon Rinsho. Japanese Journal of Clinical Medicine 50 Suppl: 116-119
Peuke, C. 2010: Hyperuricemia/gout Medizinische Monatsschrift für Pharmazeuten 33(11): 429-432
Hosoya, T. 2008: Gout and hyperuricemia: Introduction Nihon rinsho. Japanese journal of clinical medicine 66(4): 621-623
Roddy, E. 2008: Hyperuricemia, gout, and lifestyle factors Journal of Rheumatology 35(9): 1689-1691
Deray, G.; Assogba, U.; Le Hoang, P.; Brillet, G.; Baumelou, B.; Ben Hmida, M.; Jacobs, C. 1990: Cyclosporin induced hyperuricemia and gout Clinical Nephrology 33(3): 154
Roux, H.; Vovan, L.; Dutertre, P.; Serratrice, G.; Recordier, A.M. 1972: Lipid disorders in gout and in hyperuricemia with myalgia Marseille Medical 109(10): 609-625
Lindsley, H.B. 1978: Hyperuricemia and gout: eminently treatable disorders Journal of the Kansas Medical Society 79(11): 614-617
Stĕpán, J.; Sváb, V.; Kolár, J.; Susta, A.; Cáp, F. 1983: The spine and polytopic hyperostoses in gout and hyperuricemia Der Radiologe 23(8): 371-374
Matulis, A.A.; Bareĭkene, I.P.; Venalis, A.I. 1987: Use of sorption for the correction of hyperuricemia in the combined treatment of gout Terapevticheskii Arkhiv 59(12): 17-19
Gall, E.P. 1979: Hyperuricemia and gout. A modern approach to diagnosis and treatment Postgraduate Medicine 65(4): 163-7 170 172
Augur, N.A. 1978: Drug therapy reviews: chronic hepatitis American Journal of Hospital Pharmacy 35(10): 1222-1226
Kawenoki-Minc, E. 1971: Drug therapy in gout Wiadomosci Lekarskie 24(13): 1285-1291
Fadieieva, A.; Prystupa, L.; Pogorelova, O.; Kirichenko, N.; Dudchenko, I. 2016: Role of Slc2a9 and Abcg2 Gene Polymorphisms in Origin of Hyperuricemia and Gout Georgian Medical News 252: 79-83
Kohkhar, N. 1980: Hyperuricemia and gout in secondary polycythemia due to chronic obstructive pulmonary disease Journal of Rheumatology 7(1): 114-116
Robles Gil, J.; Armas, C. 1978: Various epidemiological aspects of hyperuricemia and gout in Mexico: incidence and the cardiovascular risk factor Archivos del Instituto de Cardiologia de Mexico 48(6): 1121-1141
Meade, R.H. 1979: Drug therapy reviews: antimicrobial spectrum, pharmacology and therapeutic use of erythromycin and its derivatives American Journal of Hospital Pharmacy 36(9): 1185-1189